Literature DB >> 1221925

Prognostic significance of DNA-binding capacity patterns in patients with lupus nephritis.

M K Adler, A Baumgarten, B Hecht, N J Siegel.   

Abstract

The time course of DNA binding capacity (DNA-bc) was found to correlate with the clinical course in a group of 21 patients who had biopsy-proven lupus glomerulonephritis and were treated with immunosuppressive agents. Eight patients showed a sequential DNA-bc pattern in which a high titre of anti-DNA antibody was present for a prolonged period of time all having an unfavourable clinical course. Persistently high values of DNA-bc preceded by as much as 10 months evidence of renal deterioration obtained by conventional renal function tests. Thirteen patients showed a low titre of anti-DNA antibody throughout most of their course, 12 having a favourable outcome. An initially high value of DNA-bc had no prognostic significance. These results suggest that the persistence of a high titre of anti-DNA antibody in patients with lupus glomerulonephritis is a poor prognostic sign.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1221925      PMCID: PMC1006446          DOI: 10.1136/ard.34.5.444

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  13 in total

1.  A quantitative immunochemical measure of the primary interaction between I BSA and antibody.

Authors:  R S FARR
Journal:  J Infect Dis       Date:  1958 Nov-Dec       Impact factor: 5.226

Review 2.  Immune complex disease in experimental animals and man.

Authors:  C G Cochrane; D Koffler
Journal:  Adv Immunol       Date:  1973       Impact factor: 3.543

3.  Patterns of nuclear fluorescence and DNA-binding activity.

Authors:  A Luciano; N F Rothfield
Journal:  Ann Rheum Dis       Date:  1973-07       Impact factor: 19.103

4.  Favorable outcome in diffuse proliferative glomerulonephritis of systemic lupus erythematosus.

Authors:  W V Epstein; H Grausz
Journal:  Arthritis Rheum       Date:  1974 Mar-Apr

5.  Comparison of therapeutic and immunosuppressive effects of azathioprine, prednisolone and combined therapy in NZP-NZW mice.

Authors:  B H Hahn; M K Bagby; T R Hamilton; C K Osterland
Journal:  Arthritis Rheum       Date:  1973 Mar-Apr

6.  Significance of anti-D.N.A. antibodies in systemic lupus erythematosus.

Authors:  G R Hughes
Journal:  Lancet       Date:  1971-10-16       Impact factor: 79.321

Review 7.  Mechanisms of renal injury in systemic lupus erythematosus.

Authors:  D Koffler; H G Kunkel
Journal:  Am J Med       Date:  1968-08       Impact factor: 4.965

8.  Anti-DNA activity in systemic lupus erythematosus. A diagnostic and therapeutic guide.

Authors:  G R Hughes; S A Cohen; C L Christian
Journal:  Ann Rheum Dis       Date:  1971-05       Impact factor: 19.103

9.  The clinical course of the proliferative and membranous forms of lupus nephritis.

Authors:  D S Baldwin; J Lowenstein; N F Rothfield; G Gallo; R T McCluskey
Journal:  Ann Intern Med       Date:  1970-12       Impact factor: 25.391

10.  DNA:anti-DNA complexes: their detection in systemic lupus erythematosus sera.

Authors:  R J Harbeck; E J Bardana; P F Kohler; R I Carr
Journal:  J Clin Invest       Date:  1973-04       Impact factor: 14.808

View more
  15 in total

1.  Classifying lupus.

Authors:  M L Snaith
Journal:  Br Med J (Clin Res Ed)       Date:  1983-08-06

2.  [Antinuclear antibodies in diagnosis of rheumatic diseases (author's transl)].

Authors:  K Helmke; R Scheuermann; T Boeder; M Oppermann; J Teuber; K Federlin
Journal:  Klin Wochenschr       Date:  1981-03-16

3.  Correlation of the activation of the fourth component of complement (C4) with disease activity in systemic lupus erythematosus.

Authors:  G Senaldi; V A Makinde; D Vergani; D A Isenberg
Journal:  Ann Rheum Dis       Date:  1988-11       Impact factor: 19.103

4.  DNA binding activity of serum from patients with systemic lupus erythematosus.

Authors:  J F Halsey; W A Woolery; S Oleinick; M B Kahaleh; E C Leroy
Journal:  Clin Exp Immunol       Date:  1979-03       Impact factor: 4.330

Review 5.  Autoantibody-dependent and autoantibody-independent roles for B cells in systemic lupus erythematosus: past, present, and future.

Authors:  Noam Jacob; William Stohl
Journal:  Autoimmunity       Date:  2010-02       Impact factor: 2.815

6.  A long-term immunological study of childhood onset systemic lupus erythematosus.

Authors:  C K Ting; K H Hsieh
Journal:  Ann Rheum Dis       Date:  1992-01       Impact factor: 19.103

7.  A simple, rapid ELISA method for the detection of DNA antibodies.

Authors:  R P Stokes; A Cordwell; R A Thompson
Journal:  J Clin Pathol       Date:  1982-05       Impact factor: 3.411

Review 8.  Clinical significance of antibodies to double stranded DNA (dsDNA) for systemic lupus erythematosus (SLE).

Authors:  T Swaak; R Smeenk
Journal:  Clin Rheumatol       Date:  1987-06       Impact factor: 2.980

9.  Secondary structure in denatured DNA is responsible for its reaction with antinative DNA antibodies of systemic lupus erythematosus sera.

Authors:  B D Stollar; M Papalian
Journal:  J Clin Invest       Date:  1980-08       Impact factor: 14.808

10.  Systemic lupus erythematosus: clinical manifestations and immunological parameters in 194 patients. Subgroup classification of SLE.

Authors:  J Antolin; M J Amerigo; A Cantabrana; A Roces; P Jimenez
Journal:  Clin Rheumatol       Date:  1995-11       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.